Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | CA12 | O43570 | 10/20 | 0.58 |
| ▸ | CA9 | Q16790 | 10/20 | 0.58 |
| ▸ | CA1 | P00915 | 9/20 | 0.58 |
| ▸ | CA6 | P23280 | 5/20 | 0.58 |
| ▸ | CA7 | P43166 | 5/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.58 |
| ▸ | CA4 | P22748 | 5/20 | 0.58 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.58 |
| ▸ | CA5A | P35218 | 3/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 4/20 | 0.57 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA3 | P07451 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 4/20 | 0.55 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14329528 | 0.80 | CA12 (0.55) | KDM4EALDH1A1KMT2AGLAGAA | |
| SCHEMBL30498671 | 0.80 | CA12 (0.61) | KDM4EALDH1A1KMT2ACA12CA9 | |
| SCHEMBL3362778 | 0.80 | CA12 (0.61) | KDM4EALDH1A1KMT2ACA12CA9 | |
| SCHEMBL28374638 | 0.79 | MAOB (0.69) | KDM4EALDH1A1CA12CA1CA7 | |
| 7-Cyclohexyloxycoumarin SCHEMBL14802688 | 0.78 | MAOA (0.67) | KDM4EALDH1A1KMT2AGLAGAA | |
| SCHEMBL12304245 | 0.77 | CA12 (0.81) | KDM4EALDH1A1KMT2ACA12CA9 | |
| SCHEMBL16674816 | 0.77 | MAOA (0.68) | KDM4EALDH1A1KMT2AGLAGAA | |
| SCHEMBL121759 | 0.76 | CA12 (0.52) | KDM4EALDH1A1KMT2ACA12CA9 | |
| SCHEMBL30386970 | 0.76 | CA12 (0.52) | KDM4EALDH1A1KMT2ACA12CA9 | |
| SCHEMBL24700082 | 0.75 | CA12 (0.49) | KDM4EALDH1A1KMT2AGLAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003028762-A1 | NOVEL ANTIMICROBIAL RESISTANCE BLOCKING COMPOSITIONS | ETHICON, INC. (US) | 2003-04-10 | — | — | WO | claimed |
| US-11370751-B2 | Sulfonium salt, heat- or photo-acid generator, heat- or photo-curable composition, and cured product thereof | SAN APRO LTD. (JP) | 2022-06-28 | — | — | US | disclosed |
| US-20190284134-A1 | SULFONIUM SALT, HEAT- OR PHOTO-ACID GENERATOR, HEAT- OR PHOTO-CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | SAN APRO LTD. (JP) | 2019-09-19 | — | — | US | disclosed |
| WO-2003028762-A1 | NOVEL ANTIMICROBIAL RESISTANCE BLOCKING COMPOSITIONS | ETHICON, INC. (US) | 2003-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284134-A1 | SULFONIUM SALT, HEAT- OR PHOTO-ACID GENERATOR, HEAT- OR PHOTO-CURABLE COMPOSITION, AND CURED PRODUCT THEREOF | TST, MPST, ASIC1 | KDM4E 3741/4885ALDH1A1 1326/4885KMT2A 3621/4885 |
| US-11370751-B2 | Sulfonium salt, heat- or photo-acid generator, heat- or photo-curable composition, and cured product thereof | TST, MPST, ASIC1 | KDM4E 3741/4885ALDH1A1 1326/4885KMT2A 3621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.